Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bromopride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 known ✓ | P14416 | 2/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | DRD3 | P35462 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | ACHE | P22303 | 1/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | HTR2B | P41595 | 2/20 | 0.74 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.74 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.74 |
| ▸ | HTR3B | O95264 | 1/20 | 0.74 |
| ▸ | MPO | P05164 | 1/20 | 0.74 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.74 |
| ▸ | DRD4 | P21917 | 1/20 | 0.74 |
| ▸ | HTR2A | P28223 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromopride SCHEMBL8385045 | 0.99 | ADRA2A (0.98) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| Bromopride SCHEMBL18338829 | 0.98 | ADRA2A (0.95) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| Bromopride SCHEMBL1648933 | 0.98 | ADRA2A (0.95) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| Bromopride SCHEMBL18339178 | 0.98 | ADRA2A (0.95) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| SCHEMBL11946667 | 0.86 | ADRA2A (0.76) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| SCHEMBL17068280 | 0.86 | ADRA2A (0.76) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| Bromopride SCHEMBL12497087 | 0.86 | ADRA2A (0.73) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| SCHEMBL3415873 | 0.85 | ADRA2A (0.74) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| SCHEMBL2624889 | 0.85 | ADRA2A (0.74) | ADRA2ACYP2D6DRD3CYP1A2HTR1A | |
| Metoclopramide SCHEMBL18629 | 0.85 | HTR4 (1.00) | ADRA2ACYP2D6DRD3CYP1A2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3408 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025122610-A1 | THERAPEUTIC COMBINATIONS AND METHODS FOR 5-HT3 RECEPTOR MODULATORS IN TREATING VARIOUS DISORDERS | SEROTONIX LLC (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240366639-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO INC (US) | 2024-11-07 | — | — | US | claimed |
| US-20230414702-A1 | COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER | PEPKON SAS (FR) | 2023-12-28 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-4178948-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Universidade de Santiago de Compostela (ES) | 2023-05-17 | — | — | EP | claimed |
| WO-2023049482-A1 | METHODS OF TREATING RESTRICTIVE EATING DISORDERS | ARVID THERAPEUTICS (US) | 2023-03-30 | — | — | WO | claimed |
| WO-2023016546-A1 | HETEROCYCLIC GLP-1 AGONISTS | GASHERBRUM BIO, INC. (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4035668-A1 | ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS | Chase Pharmaceuticals Corporation (US) | 2022-08-03 | — | — | EP | claimed |
| WO-2022023496-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-02-03 | — | — | WO | claimed |
| WO-2002007706-A1 | METHOD FOR COATING SOLID PARTICLES WITH A THERMOFUSIBLE AGENT, AND RESULTING COATED SOLID PARTICLES | GATTEFOSSE HOLDING (FR) | 2002-01-31 | — | — | WO | claimed |
| WO-2001034232-A1 | INHALATION NEBULIZER | Pari GmbH Spezialisten für effektive Inhalation (DE) | 2001-05-17 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000051563-A1 | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION COMPRISING A BENZAMIDE AND AT LEAST AN ABSORPTION PROMOTER | SANOFI-SYNTHELABO (FR) | 2000-09-08 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0695172-B1 | HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF | UNIV GENT (BE) | 1997-12-17 | — | — | EP | claimed |
| EP-0695172-A1 | HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF | RIJKSUNIVERSITEIT GENT LABORATORIUM VOOR FARMACEUTISCHE TECHNOLOGIE (BE) | 1996-02-07 | — | — | EP | claimed |
| WO-1994023700-A1 | HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF | RIJKSUNIVERSITEIT GENT LABORATORIUM VOOR FARMACEUTISCHE TECHNOLOGIE (BE) | 1994-10-27 | — | — | WO | claimed |
| EP-0274708-B1 | MEDICINE FOR HYPOGLYCEMIA ADMINISTRATION | Bergis, Kristian, Dr. (DE) | 1992-05-13 | — | — | EP | claimed |